Ardelyx (ARDX) Stock Forecast, Price Target & Predictions
ARDX Stock Forecast
Ardelyx stock forecast is as follows: an average price target of $8.75 (represents a 56.25% upside from ARDX’s last price of $5.60) and a rating consensus of 'Buy', based on 8 wall street analysts offering a 1-year stock forecast.
ARDX Price Target
The average price target for Ardelyx (ARDX) is $8.75 based on 1-year price targets from 8 Wall Street analysts in the past 3 months, with a price target range of $15.00 to $2.00. This represents a potential 56.25% upside from ARDX's last price of $5.60.
ARDX Analyst Ratings
According to 8 Wall Street analysts, Ardelyx's rating consensus is 'Buy'. The analyst rating breakdown for ARDX stock is 0 'Strong Buy' (0.00%), 7 'Buy' (87.50%), 1 'Hold' (12.50%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Ardelyx Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Aug 05, 2024 | Ed Arce | H.C. Wainwright | $11.00 | $6.05 | 81.82% | 96.43% |
| Jul 05, 2024 | Ed Arce | H.C. Wainwright | $10.00 | $5.29 | 89.04% | 78.57% |
| May 24, 2024 | Christopher Raymond | Raymond James | $15.00 | $7.20 | 108.31% | 167.86% |
| Dec 18, 2023 | Ryan Deschner | Raymond James | $12.00 | $6.30 | 90.33% | 114.29% |
| Dec 30, 2022 | - | Citigroup | $7.00 | $2.85 | 145.61% | 25.00% |
| Dec 29, 2022 | Laura Chico | Wedbush | $2.00 | $2.33 | -14.35% | -64.29% |
The latest Ardelyx stock forecast, released on Aug 05, 2024 by Ed Arce from H.C. Wainwright, set a price target of $11.00, which represents a 81.82% increase from the stock price at the time of the forecast ($6.05), and a 96.43% increase from ARDX last price ($5.60).
Ardelyx Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | 2 | 4 |
| Avg Price Target | - | $10.50 | $12.00 |
| Last Closing Price | $5.60 | $5.60 | $5.60 |
| Upside/Downside | -100.00% | 87.50% | 114.29% |
In the current month, the average price target of Ardelyx stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Ardelyx's last price of $5.60. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Aug 05, 2024 | H.C. Wainwright | Buy | Buy | Hold |
| Aug 02, 2024 | Wedbush | Buy | Buy | Hold |
| Jul 05, 2024 | H.C. Wainwright | Buy | Buy | Hold |
| Jul 02, 2024 | Piper Sandler | Overweight | Neutral | Downgrade |
| Jun 20, 2024 | Wedbush | Buy | Buy | Hold |
| May 24, 2024 | Piper Sandler | Overweight | Overweight | Hold |
| May 24, 2024 | Wedbush | Buy | Buy | Hold |
| May 03, 2024 | Cowen & Co. | Buy | Buy | Hold |
| May 03, 2024 | Citigroup | Buy | Buy | Hold |
| Apr 05, 2024 | Wedbush | Buy | Buy | Hold |
Ardelyx's last stock rating was published by H.C. Wainwright on Aug 05, 2024. The company gave ARDX a "Buy" rating, the same as its previous rate.
Ardelyx Financial Forecast
Ardelyx Revenue Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Sep 18 | Jun 18 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | $56.39M | $22.33M | $11.37M | $44.18M | $4.99M | - | $468.00K | $1.03M | $1.17M | $1.31M | $6.58M | $1.81M | $2.71M | $1.84M | $1.21M | $2.25M | $3.01M | $18.00K | - | $172.00K | $30.00K |
| Avg Forecast | $89.70M | $99.58M | $91.91M | $82.28M | $98.05M | $86.24M | $55.03M | $36.40M | $34.06M | $22.57M | $15.28M | $10.41M | $23.18M | $3.92M | $2.22M | $875.00K | $875.50K | $1.32M | $940.00K | $1.38M | $1.66M | $1.36M | $1.81M | $550.00K | $975.00K | $150.00K | $200.00K | $200.00K | $180.82K | $31.43K |
| High Forecast | $95.66M | $106.20M | $98.02M | $87.74M | $104.57M | $89.50M | $58.69M | $38.82M | $37.65M | $24.09M | $16.30M | $11.10M | $24.71M | $4.18M | $2.22M | $949.58K | $950.13K | $1.43M | $1.02M | $1.49M | $1.80M | $1.47M | $1.96M | $596.88K | $1.06M | $162.78K | $217.05K | $217.05K | $216.98K | $37.71K |
| Low Forecast | $81.96M | $90.99M | $83.98M | $75.18M | $89.60M | $82.62M | $50.28M | $33.26M | $32.16M | $20.81M | $13.96M | $9.51M | $21.18M | $3.58M | $2.22M | $751.59K | $752.02K | $1.13M | $807.43K | $1.18M | $1.43M | $1.17M | $1.55M | $472.43K | $837.49K | $128.84K | $171.79K | $171.79K | $144.66K | $25.14K |
| # Analysts | 4 | 3 | 4 | 3 | 5 | 8 | 5 | 4 | 5 | 7 | 6 | 3 | 2 | 2 | 2 | 3 | 4 | 5 | 6 | 3 | 3 | 3 | 3 | 3 | 2 | 3 | 4 | 5 | 7 | 18 |
| Surprise % | - | - | - | - | - | - | - | - | - | 2.50% | 1.46% | 1.09% | 1.91% | 1.27% | - | 0.53% | 1.18% | 0.89% | 1.40% | 4.79% | 1.09% | 2.00% | 1.01% | 2.21% | 2.31% | 20.09% | 0.09% | - | 0.95% | 0.95% |
Ardelyx's average Quarter revenue forecast for Dec 23 based on 5 analysts is $34.06M, with a low forecast of $32.16M, and a high forecast of $37.65M. ARDX's average Quarter revenue forecast represents a -39.60% decrease compared to the company's last Quarter revenue of $56.39M (Sep 23).
Ardelyx EBITDA Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Sep 18 | Jun 18 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 4 | 3 | 4 | 3 | 5 | 8 | 5 | 4 | 5 | 7 | 6 | 3 | 2 | 2 | 2 | 3 | 4 | 5 | 6 | 3 | 3 | 3 | 3 | 3 | 2 | 3 | 4 | 5 | 7 | 18 |
| EBITDA | - | - | - | - | - | - | - | - | - | $7.40M | $-16.62M | $-24.76M | $12.52M | $-20.55M | - | $-27.09M | $-35.06M | $-41.91M | $-43.62M | $-31.63M | $-27.14M | $-16.47M | $-23.26M | $-20.52M | $-17.88M | $-21.16M | $-23.34M | $-24.03M | $-23.46M | $-21.62M |
| Avg Forecast | $-79.74M | $-88.52M | $-81.71M | $-73.14M | $-87.17M | $-76.67M | $-48.92M | $-45.32M | $-30.28M | $-20.06M | $-13.58M | $-35.83M | $-20.60M | $-42.41M | $-1.97M | $-28.32M | $-33.89M | $-33.53M | $-32.72M | $-30.67M | $-1.48M | $-21.17M | $-21.47M | $-20.52M | $-866.73K | $-21.16M | $-21.50M | $-22.91M | $-24.61M | $-22.60M |
| High Forecast | $-72.86M | $-80.89M | $-74.66M | $-66.83M | $-79.65M | $-73.44M | $-44.70M | $-36.26M | $-28.59M | $-18.50M | $-12.41M | $-28.66M | $-18.82M | $-33.93M | $-1.97M | $-22.66M | $-27.11M | $-26.82M | $-26.17M | $-24.54M | $-1.27M | $-16.94M | $-17.18M | $-16.42M | $-744.49K | $-16.92M | $-17.20M | $-18.33M | $-19.69M | $-18.08M |
| Low Forecast | $-85.04M | $-94.40M | $-87.14M | $-78.00M | $-92.96M | $-79.56M | $-52.17M | $-54.39M | $-33.47M | $-21.41M | $-14.49M | $-42.99M | $-21.97M | $-50.90M | $-1.97M | $-33.99M | $-40.66M | $-40.23M | $-39.26M | $-36.81M | $-1.60M | $-25.41M | $-25.77M | $-24.63M | $-940.61K | $-25.39M | $-25.79M | $-27.50M | $-29.53M | $-27.12M |
| Surprise % | - | - | - | - | - | - | - | - | - | -0.37% | 1.22% | 0.69% | -0.61% | 0.48% | - | 0.96% | 1.03% | 1.25% | 1.33% | 1.03% | 18.36% | 0.78% | 1.08% | 1.00% | 20.63% | 1.00% | 1.09% | 1.05% | 0.95% | 0.96% |
5 analysts predict ARDX's average Quarter EBITDA for Dec 23 to be $-30.28M, with a high of $-28.59M and a low of $-33.47M. This is -509.27% lower than Ardelyx's previous annual EBITDA (Sep 23) of $7.40M.
Ardelyx Net Income Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Sep 18 | Jun 18 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 4 | 3 | 4 | 3 | 5 | 8 | 5 | 4 | 5 | 7 | 6 | 3 | 2 | 2 | 2 | 3 | 4 | 5 | 6 | 3 | 3 | 3 | 3 | 3 | 2 | 3 | 4 | 5 | 7 | 18 |
| Net Income | - | - | - | - | - | - | - | - | - | $6.63M | $-17.12M | $-26.77M | $10.70M | $-23.91M | - | $-28.07M | $-37.22M | $-43.59M | $-45.19M | $-33.16M | $-28.88M | $-18.11M | $-24.96M | $-22.37M | $-19.79M | $-23.54M | $-25.47M | $-26.14M | $-24.13M | $-22.29M |
| Avg Forecast | $-17.37M | $-7.49M | $-12.96M | $-20.42M | $-8.26M | $-11.81M | $-24.87M | $-46.96M | $-22.21M | $-25.24M | $-27.04M | $-37.12M | $543.03K | $-44.11M | $-44.89M | $-29.35M | $-35.03M | $-34.87M | $-33.89M | $-32.15M | $-57.30B | $-23.28M | $-23.04M | $-22.37M | $-71.25B | $-23.54M | $-23.46M | $-24.13M | $-25.30M | $-23.30M |
| High Forecast | $-15.43M | $-6.65M | $-11.51M | $-18.13M | $-7.33M | $-2.36M | $-22.08M | $-37.57M | $-9.87M | $-13.76M | $-24.01M | $-29.70M | $589.94K | $-35.29M | $-44.89M | $-23.48M | $-28.02M | $-27.90M | $-27.11M | $-25.72M | $-46.80B | $-18.63M | $-18.43M | $-17.90M | $-58.18B | $-18.83M | $-18.77M | $-19.31M | $-20.24M | $-18.64M |
| Low Forecast | $-18.87M | $-8.13M | $-14.08M | $-22.19M | $-8.97M | $-21.26M | $-27.02M | $-56.35M | $-27.14M | $-34.41M | $-29.38M | $-44.55M | $482.13K | $-52.93M | $-44.89M | $-35.22M | $-42.03M | $-41.84M | $-40.67M | $-38.58M | $-63.65B | $-27.94M | $-27.64M | $-26.85M | $-79.14B | $-28.25M | $-28.15M | $-28.96M | $-30.36M | $-27.97M |
| Surprise % | - | - | - | - | - | - | - | - | - | -0.26% | 0.63% | 0.72% | 19.69% | 0.54% | - | 0.96% | 1.06% | 1.25% | 1.33% | 1.03% | 0.00% | 0.78% | 1.08% | 1.00% | 0.00% | 1.00% | 1.09% | 1.08% | 0.95% | 0.96% |
Ardelyx's average Quarter net income forecast for Dec 23 is $-22.21M, with a range of $-27.14M to $-9.87M. ARDX's average Quarter net income forecast represents a -435.03% decrease compared to the company's last Quarter net income of $6.63M (Sep 23).
Ardelyx SG&A Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Sep 18 | Jun 18 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 4 | 3 | 4 | 3 | 5 | 8 | 5 | 4 | 5 | 7 | 6 | 3 | 2 | 2 | 2 | 3 | 4 | 5 | 6 | 3 | 3 | 3 | 3 | 3 | 2 | 3 | 4 | 5 | 7 | 18 |
| SG&A | - | - | - | - | - | - | - | - | - | $32.66M | $27.19M | $26.80M | $19.73M | $18.67M | - | $19.34M | $15.33M | $19.71M | $20.12M | $17.13M | $11.34M | $7.63M | $7.04M | $7.14M | $6.86M | $6.92M | $5.37M | $5.12M | $5.96M | $6.14M |
| Avg Forecast | $335.18M | $372.10M | $343.45M | $307.45M | $366.40M | $322.26M | $205.63M | $32.35M | $127.27M | $84.33M | $57.10M | $38.88M | $86.60M | $14.65M | $8.30M | $3.27M | $3.27M | $4.92M | $3.51M | $5.14M | $6.21M | $5.08M | $6.76M | $2.06M | $3.64M | $560.50K | $747.34K | $747.34K | $675.67K | $117.44K |
| High Forecast | $357.45M | $396.83M | $366.27M | $327.88M | $390.75M | $334.42M | $219.29M | $38.82M | $140.70M | $90.00M | $60.90M | $41.47M | $92.35M | $15.63M | $8.30M | $3.55M | $3.55M | $5.34M | $3.81M | $5.58M | $6.74M | $5.51M | $7.34M | $2.23M | $3.95M | $608.28K | $811.04K | $811.04K | $810.80K | $140.92K |
| Low Forecast | $306.26M | $340.00M | $313.82M | $280.92M | $334.79M | $308.71M | $187.89M | $25.88M | $120.17M | $77.78M | $52.18M | $35.53M | $79.13M | $13.39M | $8.30M | $2.81M | $2.81M | $4.23M | $3.02M | $4.41M | $5.34M | $4.36M | $5.81M | $1.77M | $3.13M | $481.45K | $641.94K | $641.94K | $540.53K | $93.94K |
| Surprise % | - | - | - | - | - | - | - | - | - | 0.39% | 0.48% | 0.69% | 0.23% | 1.27% | - | 5.91% | 4.69% | 4.01% | 5.73% | 3.33% | 1.83% | 1.50% | 1.04% | 3.47% | 1.88% | 12.35% | 7.19% | 6.85% | 8.82% | 52.27% |
Ardelyx's average Quarter SG&A projection for Dec 23 is $127.27M, based on 5 Wall Street analysts, with a range of $120.17M to $140.70M. The forecast indicates a 289.64% rise compared to ARDX last annual SG&A of $32.66M (Sep 23).
Ardelyx EPS Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jul 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Sep 18 | Jun 18 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 4 | 3 | 4 | 3 | 5 | 8 | 5 | 4 | 5 | 7 | 6 | 3 | 2 | 2 | 2 | 3 | 4 | 5 | 6 | 3 | 3 | 3 | 3 | 3 | 2 | 3 | 4 | 5 | 7 | 18 |
| EPS | - | - | - | - | - | - | - | - | - | $0.03 | $-0.00 | $-0.13 | $0.06 | $-0.14 | - | $-0.21 | $-0.32 | $-0.42 | $-0.45 | $-0.34 | $-0.32 | $-0.20 | $-0.28 | $-0.25 | $-0.27 | $-0.37 | $-0.41 | $-0.42 | $-0.39 | $-0.42 |
| Avg Forecast | $-0.07 | $-0.03 | $-0.06 | $-0.09 | $-0.04 | $-0.05 | $-0.11 | $-0.15 | $-0.09 | $-0.11 | $-0.12 | $-0.10 | - | $-0.17 | $-0.19 | $-0.22 | $-0.30 | $-0.35 | $-0.37 | $-0.33 | $-0.26 | $-0.28 | $-0.27 | $-0.25 | $-0.32 | $-0.37 | $-0.38 | $-0.39 | $-0.43 | $-0.46 |
| High Forecast | $-0.07 | $-0.03 | $-0.05 | $-0.08 | $-0.03 | $-0.01 | $-0.09 | $-0.13 | $-0.04 | $-0.06 | $-0.10 | $-0.09 | - | $-0.15 | $-0.19 | $-0.18 | $-0.25 | $-0.29 | $-0.30 | $-0.27 | $-0.21 | $-0.23 | $-0.22 | $-0.20 | $-0.27 | $-0.30 | $-0.31 | $-0.32 | $-0.34 | $-0.37 |
| Low Forecast | $-0.08 | $-0.03 | $-0.06 | $-0.09 | $-0.04 | $-0.09 | $-0.12 | $-0.16 | $-0.12 | $-0.15 | $-0.13 | $-0.11 | - | $-0.18 | $-0.19 | $-0.25 | $-0.34 | $-0.39 | $-0.41 | $-0.37 | $-0.29 | $-0.31 | $-0.30 | $-0.28 | $-0.36 | $-0.41 | $-0.42 | $-0.43 | $-0.52 | $-0.55 |
| Surprise % | - | - | - | - | - | - | - | - | - | -0.28% | 0.00% | 1.29% | 25.92% | 0.83% | - | 0.95% | 1.05% | 1.20% | 1.23% | 1.03% | 1.22% | 0.71% | 1.05% | 1.00% | 0.83% | 1.00% | 1.07% | 1.08% | 0.91% | 0.91% |
According to 5 Wall Street analysts, Ardelyx's projected average Quarter EPS for Dec 23 is $-0.09, with a low estimate of $-0.12 and a high estimate of $-0.04. This represents a -415.60% decrease compared to ARDX previous annual EPS of $0.03 (Sep 23).
Ardelyx Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| HEPA | Hepion Pharmaceuticals | $0.72 | $70.00 | 9622.22% | Buy |
| LXRX | Lexicon Pharmaceuticals | $1.61 | $10.00 | 521.12% | Buy |
| VSTM | Verastem | $2.40 | $8.33 | 247.08% | Buy |
| PDSB | PDS Bio | $2.93 | $9.00 | 207.17% | Buy |
| INZY | Inozyme Pharma | $4.98 | $14.00 | 181.12% | Buy |
| IBRX | ImmunityBio | $3.38 | $8.00 | 136.69% | Sell |
| TERN | Terns Pharmaceuticals | $7.81 | $12.50 | 60.05% | Buy |
| MREO | Mereo BioPharma Group | $4.32 | $6.75 | 56.25% | Buy |
| ARDX | Ardelyx | $5.60 | $8.75 | 56.25% | Buy |
| ZURA | Zura Bio | $3.62 | $5.00 | 38.12% | Buy |
| MCRB | Seres Therapeutics | $0.95 | $1.25 | 31.58% | Buy |
| HOOK | HOOKIPA Pharma | $4.74 | $3.00 | -36.71% | Buy |
ARDX Forecast FAQ
Is Ardelyx a good buy?
Yes, according to 8 Wall Street analysts, Ardelyx (ARDX) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 7 'Buy' recommendations, accounting for 87.50% of ARDX's total ratings.
What is ARDX's price target?
Ardelyx (ARDX) average price target is $8.75 with a range of $2 to $15, implying a 56.25% from its last price of $5.6. The data is based on 8 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will Ardelyx stock go up soon?
According to Wall Street analysts' prediction for ARDX stock, the company can go up by 56.25% (from the last price of $5.6 to the average price target of $8.75), up by 167.86% based on the highest stock price target, and down by -64.29% based on the lowest stock price target.
Can Ardelyx stock reach $8?
ARDX's average twelve months analyst stock price target of $8.75 supports the claim that Ardelyx can reach $8 in the near future.
What are Ardelyx's analysts' financial forecasts?
Ardelyx's analysts financial forecasts for the fiscal year (Dec 2024) are as follows: average revenue is $275.72M (high $291.57M, low $255.75M), average EBITDA is $-258M (high $-234M, low $-279M), average net income is $-91.899M (high $-69.341M, low $-114M), average SG&A $926.64M (high $983.28M, low $857.27M), and average EPS is $-0.339 (high $-0.266, low $-0.404). ARDX's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $363.47M (high $387.62M, low $332.11M), average EBITDA is $-323M (high $-295M, low $-345M), average net income is $-58.244M (high $-51.712M, low $-63.275M), average SG&A $1.36B (high $1.45B, low $1.24B), and average EPS is $-0.248 (high $-0.22, low $-0.27).
Did the ARDX's actual financial results beat the analysts' financial forecasts?
Based on Ardelyx's last annual report (Dec 2022), the company's revenue was $52.16M, beating the average analysts forecast of $30.19M by 72.75%. Apple's EBITDA was $-62.126M, missing the average prediction of $-93.311M by -33.42%. The company's net income was $-67.207M, missing the average estimation of $-118M by -42.95%. Apple's SG&A was $76.6M, missing the average forecast of $112.82M by -32.11%. Lastly, the company's EPS was $-0.42, missing the average prediction of $-0.58 by -27.57%. In terms of the last quarterly report (Sep 2023), Ardelyx's revenue was $56.39M, beating the average analysts' forecast of $22.57M by 149.86%. The company's EBITDA was $7.4M, missing the average prediction of $-20.063M by -136.87%. Ardelyx's net income was $6.63M, missing the average estimation of $-25.235M by -126.27%. The company's SG&A was $32.66M, missing the average forecast of $84.33M by -61.27%. Lastly, the company's EPS was $0.03, missing the average prediction of $-0.108 by -127.89%